MG
MustGrow Biologics Corp.
MGROF · OTC
$0.30 -5.09% (-$0.02)
1M -2.03%
Market Cap $26.6M
P/E Ratio -
Div. Yield -
ROE 218.71%
Bulios Fair Price
$0.18
40.7% downside
Current Price
$0.3
Undervalued Fair Value Overvalued
According to Bulios Fair Price, MGROF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
2 /100
Expensive P/S 8.33x
P/B 5.26x
P/E N/A
Growth
78 /100
Growing Rev. growth 985.18%
Book val. growth 45.11%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 51.97%
FCF margin 135.96%
Net margin 174.44%
Quality
6 /100
Poor ROIC 76.02%
Asset turnover 0.45x
ROE 218.71%
Debt
69 /100
Low Debt/Equity 0.10x
Int. coverage -84.48x
Current ratio 3.63x
Stability
2 /100
Unstable Beta 0.33x
Profitable years 0
Rev. volatility 41,399.12%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MGROF
Online
Sector
Basic Materials
Industry
Agricultural Inputs
CEO
Corey J. Giasson
Employees
10
Headquarters
Saskatoon
Upcoming events
01 DEC
Earnings
Upcoming earnings report